ATE384127T1 - Kostimulatorisches t-zell-oberflächen-antigen slam - Google Patents

Kostimulatorisches t-zell-oberflächen-antigen slam

Info

Publication number
ATE384127T1
ATE384127T1 AT95942422T AT95942422T ATE384127T1 AT E384127 T1 ATE384127 T1 AT E384127T1 AT 95942422 T AT95942422 T AT 95942422T AT 95942422 T AT95942422 T AT 95942422T AT E384127 T1 ATE384127 T1 AT E384127T1
Authority
AT
Austria
Prior art keywords
slam
stimulatory
cell surface
surface antigen
antigen
Prior art date
Application number
AT95942422T
Other languages
English (en)
Inventor
Gregorio Aversa
Chia-Chun Chang
Benjamin Cocks
Vries Jan De
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/348,792 external-priority patent/US5576423A/en
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE384127T1 publication Critical patent/ATE384127T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95942422T 1994-12-02 1995-11-29 Kostimulatorisches t-zell-oberflächen-antigen slam ATE384127T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/348,792 US5576423A (en) 1994-12-02 1994-12-02 Antibodies to the slam protein expressed on activated T cells
US48177795A 1995-06-07 1995-06-07

Publications (1)

Publication Number Publication Date
ATE384127T1 true ATE384127T1 (de) 2008-02-15

Family

ID=26995892

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95942422T ATE384127T1 (de) 1994-12-02 1995-11-29 Kostimulatorisches t-zell-oberflächen-antigen slam

Country Status (10)

Country Link
US (1) US6399065B1 (de)
EP (2) EP1867720A3 (de)
JP (2) JPH10510707A (de)
AR (1) AR002004A1 (de)
AT (1) ATE384127T1 (de)
AU (1) AU4365196A (de)
CA (1) CA2206610A1 (de)
DE (1) DE69535690T2 (de)
ES (1) ES2301164T3 (de)
WO (1) WO1996017060A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1522858A1 (de) * 2003-10-10 2005-04-13 Jean-Christophe Roegel Methoden für Selektion von Verbindungen unter Verwendung von Antikörpern mit Aktivität als Agonist, Antagonist oder allosterischen Modulatoren
CN108064166A (zh) * 2014-10-23 2018-05-22 戊瑞治疗有限公司 Slamf1拮抗剂及其用途
GB201700621D0 (en) 2017-01-13 2017-03-01 Guest Ryan Dominic Method,device and kit for the aseptic isolation,enrichment and stabilsation of cells from mammalian solid tissue
GB201910605D0 (en) * 2019-07-24 2019-09-04 Immetacyte Ltd Tumour infltracting lymphocyte therapy amd uses thereo
BR112022011795A2 (pt) 2019-12-20 2022-08-30 Instil Bio Uk Ltd Métodos para preparar e isolar uma população terapêutica de linfócitos e para tratar câncer em um indivíduo, população terapêutica de linfócitos, bolsa criopreservada, recipiente flexível, e, sistema para extração de linfócitos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56145222A (en) * 1980-04-28 1981-11-11 Toshiyuki Hamaoka Improved antibody and its preparation
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US5389520A (en) * 1989-02-21 1995-02-14 Dana-Farber Cancer Institute, Inc. Specific detection of cell surface receptor leukocyte adhesion molecule-1
EP0537293A4 (en) * 1990-07-02 1993-09-08 Bristol-Myers Company Ligand for cd28 receptor on b cells and methods
CA2580812A1 (en) * 1991-06-27 1993-01-07 Bristol-Myers Squibb Company Ctla4 receptor, fusion proteins containing it and uses thereof

Also Published As

Publication number Publication date
CA2206610A1 (en) 1996-06-06
JPH10510707A (ja) 1998-10-20
AR002004A1 (es) 1998-01-07
WO1996017060A1 (en) 1996-06-06
ES2301164T3 (es) 2008-06-16
US6399065B1 (en) 2002-06-04
DE69535690T2 (de) 2009-01-15
DE69535690D1 (de) 2008-03-06
EP1867720A2 (de) 2007-12-19
EP0795014A1 (de) 1997-09-17
EP1867720A3 (de) 2008-01-09
EP0795014B1 (de) 2008-01-16
MX9703956A (es) 1997-09-30
JP2007008958A (ja) 2007-01-18
AU4365196A (en) 1996-06-19

Similar Documents

Publication Publication Date Title
HUP0100094A3 (en) Novel surface antigen
FI20115005L (fi) Melanooma-antigeeni
FI964235A0 (fi) Melanooma-antigeeni
DE69432921D1 (de) Schnittstelleneinrichtung
DE59503710D1 (de) Reinigungsgerät
DE69625215D1 (de) Handreinigungsmittel
DE59506126D1 (de) Kehrfahrzeug
DE59601627D1 (de) Kehrfahrzeug
FI950388A0 (fi) Puhdistusväline
DE69534484D1 (de) Epimerase
FI971485A0 (fi) Sits
ATE384127T1 (de) Kostimulatorisches t-zell-oberflächen-antigen slam
DE69505140D1 (de) Schleifartikel
DE69631862D1 (de) Reinigungsgerät
DE69525607D1 (de) Poliervorrichtung
DE69624766D1 (de) Oberflächenwellenresonator
KR960017001U (ko) 아암 레스트
DE69527909D1 (de) Schleifmaterialen
DE59502822D1 (de) Thermokanne
GB9726147D0 (en) Antigens
KR960000709U (ko) 연마장치
FI1995U1 (fi) Madrass
FI1994U1 (fi) Madrass
KR960033723U (ko) 연마기
KR970000650U (ko) 연마기

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties